Latanoprostene bunod ophthalmic solution 0.024% in the treatment of open-angle glaucoma: design, development, and place in therapy

Addis VM, Miller-Ellis E

Clinical Ophthalmology 2018, 12:2649-2657

Published Date: 20 December 2018